ISANSYS LTD

In March, a ground-breaking project to monitor young patients at home won funding from NHS England’s Transformation Directorate to create a hospital from home for acutely unwell children.

The technology, the Patient Status Engine developed by Isansys, allows hospital clinicians to monitor young patients at home as if they were in hospital, providing the patients’ vital signs continuously at a central monitoring station or on mobile devices 24 hours a day, ultimately integrating this key data into the electronic medical record system.

Using this information, clinicians and community care teams can work together to develop personalised care plans for young patients at home, eliminating the stress and disruption of admission, or readmission, to hospital.

Isansys says its Patient Status Engine is the most complete, scalable and simple-to-use advanced patient monitoring platform. The company has subsidiaries in Germany and India, and through a network of distributors and partners, it works with healthcare providers globally seeking lower cost monitoring and higher quality data.

To date more than 20,000 Lipogems Equine procedures have been carried out, with a 95 per cent success rate, says the company. The treatment can be used on pets, but also on sports horses and ponies, saving them from career-ending injuries or conditions and allowing them to race, jump or play polo again within months.

Lipocast Biotech UK continues to research and develop regenerative science on equines. And there’s good news for dog-lovers – the treatment has recently been adapted for use in canine veterinary practice.